We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Invitation Homes
INVH
$17.6B
| $400K | 0.2% |
+14,403
| New | +$402K |
|
127
Ramaco Resources Class A
METC
$664M
| $399K | 0.2% |
+22,178
| New | +$583K |
|
128
Micron Technology
MU
$1.02T
| $399K | 0.2% |
+1,397
| New | +$321K |
|
129
Vital Farms
VITL
$569M
| $396K | 0.2% |
+12,407
| New | +$437K |
|
|
AGNT
130
AGNT Inc
AGNT
$690M
| $396K | 0.2% |
+43,765
| New | +$462K |
|
131
Vericel Corp
VCEL
$2.31B
| $394K | 0.2% |
+10,949
| New | +$402K |
|
132
Sanofi
SNY
$105B
| $394K | 0.2% |
+8,121
| New | +$403K |
|
133
TE Connectivity
TEL
$60.2B
| $393K | 0.2% |
+1,727
| New | +$399K |
|
134
JB Hunt Transport Services
JBHT
$26.4B
| $393K | 0.2% |
+2,020
| New | +$347K |
|
|
ARX
135
Accelerant Holdings
ARX
$3.19B
| $390K | 0.2% |
23,839
+7,566
| +46% | +$107K |
|
136
Arlo Technologies
ARLO
$1.51B
| $389K | 0.2% |
27,831
+10,794
| +63% | +$170K |
|
|
MSIF
137
MSC Income Fund Inc
MSIF
$514M
| $389K | 0.2% |
+29,601
| New | +$393K |
|
138
Quanex
NX
$863M
| $388K | 0.2% |
25,253
+2,711
| +12% | +$38.3K |
|
|
ILPT
139
Industrial Logistics Properties Trust
ILPT
$601M
| $388K | 0.2% |
70,084
+43,618
| +165% | +$241K |
|
|
CBC
140
Central Bancompany Inc
CBC
$7.69B
| $388K | 0.2% |
+16,076
| New | +$378K |
|
141
AT&T
T
$167B
| $388K | 0.2% |
+15,610
| New | +$395K |
|
142
Trane Technologies
TT
$107B
| $388K | 0.2% |
+996
| New | +$412K |
|
143
BlackSky Technology
BKSY
$903M
| $386K | 0.2% |
+20,567
| New | +$419K |
|
|
OMDA
144
Omada Health Inc
OMDA
$1.22B
| $385K | 0.2% |
+24,415
| New | +$495K |
|
145
Cognex
CGNX
$10.2B
| $385K | 0.19% |
+10,696
| New | +$433K |
|
146
Gaming and Leisure Properties
GLPI
$12.8B
| $377K | 0.19% |
+8,431
| New | +$374K |
|
147
Cheniere Energy
LNG
$53.6B
| $375K | 0.19% |
1,927
-28
| -1% | -$5.88K |
|
|
CMRC
148
Commerce.com Inc Series 1
CMRC
$234M
| $372K | 0.19% |
+90,174
| New | +$416K |
|
149
Inogen
INGN
$171M
| $371K | 0.19% |
+55,240
| New | +$414K |
|
150
SkyWater Technology
SKYT
$1.55B
| $371K | 0.19% |
+20,441
| New | +$355K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.